Bicocca Open Archive

Logo unimib boa
ARCANGELI, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.651
AS - Asia 11.492
EU - Europa 5.482
SA - Sud America 1.413
Continente sconosciuto - Info sul continente non disponibili 786
AF - Africa 217
OC - Oceania 11
Totale 32.052
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.731
SG - Singapore 5.829
IT - Italia 1.921
VN - Vietnam 1.530
HK - Hong Kong 1.407
CN - Cina 1.309
BR - Brasile 1.048
RU - Federazione Russa 866
CA - Canada 744
DE - Germania 642
IE - Irlanda 624
BD - Bangladesh 480
SE - Svezia 371
FR - Francia 258
GB - Regno Unito 212
IN - India 209
UA - Ucraina 159
AR - Argentina 142
KR - Corea 106
ID - Indonesia 100
FI - Finlandia 91
IQ - Iraq 77
NL - Olanda 75
MX - Messico 73
TR - Turchia 72
PK - Pakistan 61
ZA - Sudafrica 60
EC - Ecuador 55
CO - Colombia 53
AT - Austria 46
PH - Filippine 44
SA - Arabia Saudita 44
ES - Italia 43
PL - Polonia 42
MA - Marocco 35
VE - Venezuela 31
JP - Giappone 30
UZ - Uzbekistan 30
CL - Cile 27
CH - Svizzera 26
EG - Egitto 26
JM - Giamaica 24
PY - Paraguay 20
TH - Thailandia 20
TN - Tunisia 20
MY - Malesia 19
HN - Honduras 18
JO - Giordania 18
AE - Emirati Arabi Uniti 17
CZ - Repubblica Ceca 15
UY - Uruguay 15
CR - Costa Rica 14
KE - Kenya 14
DK - Danimarca 13
ET - Etiopia 13
LT - Lituania 13
BO - Bolivia 11
KZ - Kazakistan 11
PE - Perù 11
AL - Albania 10
NP - Nepal 10
AU - Australia 9
DZ - Algeria 9
OM - Oman 9
PT - Portogallo 9
GT - Guatemala 8
PS - Palestinian Territory 8
TT - Trinidad e Tobago 8
GR - Grecia 7
SN - Senegal 7
IL - Israele 6
NI - Nicaragua 6
PA - Panama 6
RO - Romania 6
AZ - Azerbaigian 5
KG - Kirghizistan 5
LB - Libano 5
LY - Libia 5
PR - Porto Rico 5
RS - Serbia 5
SY - Repubblica araba siriana 5
BG - Bulgaria 4
DO - Repubblica Dominicana 4
IR - Iran 4
SC - Seychelles 4
SI - Slovenia 4
ZM - Zambia 4
AM - Armenia 3
AO - Angola 3
BB - Barbados 3
BE - Belgio 3
BH - Bahrain 3
BW - Botswana 3
EE - Estonia 3
EU - Europa 3
HR - Croazia 3
NG - Nigeria 3
SV - El Salvador 3
AG - Antigua e Barbuda 2
BT - Bhutan 2
Totale 31.229
Salva come PNG Salva come JPEG
Città #
Hong Kong 1.391
Ashburn 1.307
Singapore 1.288
Fairfield 1.048
Ann Arbor 823
San Jose 802
Toronto 654
Dublin 617
Ho Chi Minh City 473
Frankfurt am Main 462
Milan 451
Santa Clara 440
Woodbridge 431
Seattle 424
Wilmington 409
Houston 355
Hanoi 353
Cambridge 341
New York 310
Council Bluffs 276
Chicago 264
Los Angeles 239
Princeton 238
The Dalles 233
Hefei 219
Rome 165
Beijing 153
Dallas 135
Lauterbourg 135
Moscow 135
Chandler 123
Buffalo 114
Altamura 110
Lawrence 108
Seoul 102
São Paulo 99
Jacksonville 92
Dearborn 89
Munich 76
San Diego 71
Da Nang 68
Nanjing 67
Columbus 61
Boardman 56
Phoenix 55
Helsinki 54
Rio de Janeiro 45
Haiphong 44
London 43
Shanghai 43
Guangzhou 42
Jakarta 42
Andover 41
Salt Lake City 39
Nuremberg 35
Warsaw 35
Biên Hòa 32
Orem 28
Tashkent 27
Dong Ket 26
Ha Long 26
Johannesburg 26
Ninh Bình 26
Ottawa 26
Tokyo 26
Atlanta 25
Brooklyn 25
Naples 25
Shenyang 25
Turin 25
Hebei 24
Belo Horizonte 23
Lahore 23
Nanchang 23
Florence 22
Vienna 22
Baghdad 21
Changsha 21
Denver 21
San Francisco 21
Can Tho 20
Chennai 20
Curitiba 20
Figino 20
Tampa 20
Dhaka 19
Lappeenranta 19
Mexico City 19
Boston 18
Brasília 18
Bắc Ninh 18
Charlotte 18
Guayaquil 18
Hải Dương 18
Palermo 18
Thái Nguyên 18
Zurich 18
Campinas 17
Jiaxing 17
Stockholm 17
Totale 17.284
Salva come PNG Salva come JPEG
Nome #
Effetti immunologici della radioterapia 645
The ‘Liaisons dangereuses’ Between Lung Cancer and Interstitial Lung Diseases: A Focus on Acute Exacerbation 562
Combination of novel systemic agents and radiotherapy for solid tumors – part I: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment efficacy 461
Leukotoxicity after moderately Hypofractionated radiotherapy versus conventionally fractionated dose escalated radiotherapy for localized prostate Cancer: A secondary analysis from a randomized study 438
Treatment outcomes and patterns of radiologic appearance after hypofractionated image-guided radiotherapy delivered with helical tomotherapy (HHT) for lung tumours 397
Validation of an easy questionnaire on the assessment of salt habit: the MINISAL-SIIA Study Program 390
Single-Isocenter Linac-Based Radiosurgery for Brain Metastases with Coplanar Arcs: A Dosimetric and Clinical Analysis 363
International validation of the EORTC QLQ-PRT20 module for assessment of quality of life symptoms relating to radiation proctitis: a phase IV study 355
Extreme hypofractionation for early prostate cancer: Biology meets technology 343
"Hit the primary": A paradigm shift in the treatment of metastatic prostate cancer? 341
Consensus statements on ablative radiotherapy for oligometastatic prostate cancer: A position paper of Italian Association of Radiotherapy and Clinical Oncology (AIRO) 339
Consolidative ablative radiotherapy improves outcomes in oligometastatic non-small cell lung cancer: A further step toward new evidence 332
Macroscopic Hematuria After Conventional or Hypofractionated Radiation Therapy: Results From a Prospective Phase 3 Study 330
Radiation therapy does not increase survival in addition to standard androgen deprivation therapy for metastatic prostate cancer: An old, faded picture? 329
Combination of novel systemic agents and radiotherapy for solid tumors – Part II: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment toxicity 328
Combination of androgen deprivation therapy and radiotherapy for localized prostate cancer in the contemporary era 324
Moderate hypofractionation for prostate cancer 324
Re-irradiation for esophageal cancer 322
Will SBRT replace conventional radiotherapy in patients with low-intermediate risk prostate cancer? A review 322
A Systematic Review of Radical Cystectomy Versus Organ Preserving Trimodal Therapy in Muscle-Invasive Bladder Cancer 320
Moderately escalated hypofractionated (chemo) radiotherapy delivered with helical intensity-modulated technique in stage III unresectable non-small cell lung cancer 318
Is two-dimensional field definition sufficient for pelvic node coverage in rectal cancer compared to technical three-dimensional definition? 310
Post-operative management of brain metastases: GRADE-based clinical practice recommendations on behalf of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 299
Association between treatment-related lymphopenia and survival in glioblastoma patients following postoperative chemoradiotherapy 294
« Augmented radiotherapy » in the management of high-risk prostate cancer (PCa): A systematic review 292
Stereotactic Body Radiation Therapy With Ablative Dose on Liver Metastases: Radiation-induced Liver Disease (RILD) and Toxicity Assessment 289
Guidelines on prostate carcinoma - AIRO, 2016 287
Optimal scheduling of hypofractionated radiotherapy for localized prostate cancer: A systematic review and metanalysis of randomized clinical trials 284
Dose-escalated Radiotherapy for Stage III Unresectable Non-small Cell Lung Cancer: Have We Come to a Standstill? 283
Oligometastasis and local ablation in the era of systemic targeted and immunotherapy 282
Urethra-sparing prostate cancer radiotherapy: Current practices and future insights from an international survey 274
Letter to the Editor regarding ESTRO-ASTRO guidelines on lung cancer radiotherapy during COVID-19 pandemic 272
Synchronized Contrast-Enhanced 4DCT Simulation for Target Volume Delineation in Abdominal SBRT 260
10-yr Results of Moderately Hypofractionated Postoperative Radiotherapy for Prostate Cancer Focused on Treatment Related Toxicity 253
Moderate hypofractionated helical tomotherapy for localized prostate cancer: preliminary report of an observational prospective study 245
Stereotactic Body Radiation Therapy for Prostate Cancer is Getting Mature: 10-Year Outcomes From 3 Prospective Trials 240
In vivo dosimetry of total body irradiation patients: A 10 year retrospective analysis 239
Treatment outcome and compliance to dose-intensified linac-based SBRT for unfavorable prostate tumors using a novel real-time organ-motion tracking 237
COVID-19 Outbreak and Cancer Radiotherapy Disruption in Lombardy, Northern Italy 236
A critical review on oligometastatic disease: a radiation oncologist’s perspective 234
Intrafraction Prostate Motion Management During Dose-Escalated Linac-Based Stereotactic Body Radiation Therapy 233
Almost one year of COVID-19 pandemic: how radiotherapy centers have counteracted its impact on cancer treatment in Lombardy, Italy. CODRAL/AIRO-L study 228
Acute Toxicity and Quality of Life in a Post-Prostatectomy Ablative Radiation Therapy (POPART) Multicentric Trial 226
Can volumetric modulated arc therapy with flattening filter free beams play a role in stereotactic body radiotherapy for liver lesions? A volume-based analysis 226
Attitudes, practices and perspectives on imaging strategies in prostate cancer: a national cross-sectional survey involving expert radiation oncologists on behalf of AIRO (Italian association of radiotherapy and clinical oncology) GU group 226
Lexicographic optimization-based planning for stereotactic radiosurgery of brain metastases 223
Radical cystectomy versus organ-sparing trimodality treatment in muscle-invasive bladder cancer: A systematic review of clinical trials 223
A systematic review and meta-analysis of clinical trials of bladder-sparing trimodality treatment for muscle-invasive bladder cancer (MIBC) 222
Short-term pain control after palliative radiotherapy for uncomplicated bone metastases: a prospective cohort study 221
Safety culture to improve accidental event reporting in radiotherapy 221
Dosimetric and Clinical Prognostic Factors in Single-Isocenter Linac-Based Stereotactic Radiotherapy for Brain Metastases 219
Policies for reirradiation of recurrent high-grade gliomas: a survey among Italian radiation oncologists 219
Management of patients with extensive small-cell lung cancer in the immunotherapy era: an Italian consensus through a Delphi approach 215
Long-term outcomes of volume de-escalation for breast nodal irradiation 215
High-dose-rate brachytherapy as monotherapy for localized prostate cancer using three different doses - 14 years of single-centre experience 213
Analysis of patients with locally advanced rectal cancer given neoadjuvant radiochemotherapy with or without RT dose intensification: A multicenter retrospective study – ATLANTIS part I 210
Time to Next Treatment Following Sub-Ablative Progression Directed Radiation Therapy for Oligoprogressive Non-Small-Cell Lung Cancer 209
Ablative Radiation Therapy for Unfavorable Prostate Tumors (ABRUPT): Preliminary Analysis of Toxicity and Quality of Life from a Prospective Study 209
Toxicity profile and Patient-Reported outcomes following salvage Stereotactic Ablative Radiation Therapy to the prostate Bed: The POPART multicentric prospective study 208
Moderate hypofractionation in high-risk, organ-confined prostate cancer: Final results of a phase III randomized trial 208
Updated results and patterns of failure in a randomized hypofractionation trial for high-risk prostate cancer 207
Toxicity and cosmesis outcomes after single fraction partial breast irradiation in early stage breast cancer 205
A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study 204
Treatment Optimization in Linac-Based SBRT for Localized Prostate Cancer: A Single-Arc versus Dual-Arc Plan Comparison 204
GUROPA survey: genito-urinary radiation oncology prescription attitudes 203
Radical radiation therapy for oligometastatic breast cancer: Results of a prospective phase II trial 202
Dosimetric Impact of Intrafraction Prostate Motion and Interfraction Anatomical Changes in Dose-Escalated Linac-Based SBRT 201
Is stereotactic body radiation therapy an attractive option for unresectable liver metastases? A preliminary report from a phase 2 trial 200
Automated segmentation in pelvic radiotherapy: A comprehensive evaluation of ATLAS-, machine learning-, and deep learning-based models 198
Postoperative Hypofractionated Radiotherapy for Prostate Cancer 197
Hypofractionated high-dose radiation therapy for prostate cancer: long-term results of a multi-institutional phase II trial. 196
A predictive model of polymetastatic disease from a multicenter large retrospectIve database on colorectal lung metastases treated with stereotactic ablative radiotherapy: The RED LaIT-SABR study 194
Patterns of CT lung injury and toxicity after stereotactic radiotherapy delivered with helical tomotherapy in early stage medically inoperable NSCLC 193
Salvage therapy of intraprostatic failure after radical external-beam radiotherapy for prostate cancer: A review. 190
Hypofractionated radiotherapy for organ-confined prostate cancer: Is less more? 190
Phase I-II study of intraoperative radiation therapy (IORT) after radical prostatectomy for prostate cancer 189
Analysis of toxicity in patients with high risk prostate cancer treated with intensity-modulated pelvic radiation therapy and simultaneous integrated dose escalation to prostate area 188
Stereotactic body radiation therapy salvage reirradiation of radiorecurrent prostatic carcinoma relapsed in the prostatic bed 188
DVHs evaluation in brain metastases stereotactic radiotherapy treatment plans 188
Stereotactic body radiation therapy for liver tumours using flattening filter free beam: dosimetric and technical considerations 186
Re-irradiation with curative intent in patients with squamous cell carcinoma of the head and neck: a national survey of usual practice on behalf of the Italian Association of Radiation Oncology (AIRO) 184
Clinical and Dosimetric Predictors of Acute Toxicity After a 4-Week Hypofractionated External Beam Radiotherapy Regimen for Prostate Cancer: Results From a Multicentric Prospective Trial 178
Epidemiology of prostate cancer and treatment remarks. 177
EORTC radiation proctitis-specific quality of life module - pretesting in four European countries 177
1539 poster TUMOR CONTROL PROBABILITY IN STEREOTACTIC RADIO-SURGERY FOR BRAIN METASTASES 176
Retrospective comparison of external beam radiotherapy and radical prostatectomy in high-risk, clinically localized prostate cancer 175
Phase II study of a four-week hypofractionated external beam radiotherapy regimen for prostate cancer: report on acute toxicity 175
Intensity-modulated pelvic radiation therapy and simultaneous integrated boost to the prostate area in patients with high-risk prostate cancer: a preliminary report of disease control 172
Review and uses of stereotactic body radiation therapy for oligometastases 171
Comprehensive dosimetric and clinical evaluation of lexicographic optimization-based planning for cervical cancer 170
Dose and polymorphic genes xrcc1, xrcc3, gst play a role in the risk of developing erythema in breast cancer patients following single shot partial breast irradiation after conservative surgery 170
Moderately escalated hypofractionated (chemo) radiotherapy delivered with helical intensity-modulated technique in stage III unresectable non-small cell lung cancer 170
Retreatment for prostate cancer with stereotactic body radiation therapy (SBRT): Feasible or foolhardy? 170
Color Doppler quantitative measures to predict outcome of biopsies in prostate cancer 169
Stereotactic ablative radiation therapy in renal cell carcinoma: From oligometastatic to localized disease 168
A prospective phase III randomized trial of hypofractionation versus conventional fractionation in patients with high-risk prostate cancer 168
From chemotherapy to target therapies associated with radiation in the treatment of NSCLC: a durable marriage? 167
Mathematical Model for Evaluating Incidence of Acute Rectal Toxicity During Conventional or Hypofractionated Radiotherapy Courses for Prostate Cancer 167
Hypofractionation and Stereotactic Treatment: Clinical Data 166
Accelerated hyperfractionated radiotherapy and concurrent protracted venous infusion chemotherapy in locally advanced head and neck cancer 164
Totale 24.724
Salva come PNG Salva come JPEG
Categoria #
all - tutte 105.806
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 105.806
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022725 0 0 0 49 27 53 42 178 41 35 88 212
2022/20231.648 275 484 194 75 69 271 30 56 100 15 48 31
2023/20241.502 30 23 34 144 164 358 385 29 169 26 32 108
2024/20258.242 148 583 159 142 278 93 513 192 525 733 2.408 2.468
2025/202611.966 1.184 992 875 1.209 980 503 1.450 587 937 910 1.251 1.088
2026/20272.463 444 609 1.227 183 0 0 0 0 0 0 0 0
Totale 32.052